| 1 |
34952465 | Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway. | 2022 Feb |
3 |
| 2 |
34405005 | Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. | 2021 |
1 |
| 3 |
32350909 | Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-κB pathway activation. | 2020 Sep |
1 |
| 4 |
31141702 | Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. | 2019 Jul |
1 |
| 5 |
31287161 | Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment? | 2019 Sep 15 |
1 |
| 6 |
20594187 | Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. | 2010 Nov |
1 |
| 7 |
18536579 | NF-kappaB in the pathogenesis and treatment of multiple myeloma. | 2008 Jul |
1 |